Abstract
PMLRAR (retinoic acid receptor)α is the hallmark protein of acute promyelocytic leukaemia, a highly malignant subtype of acute myeloid leukaemia that accounts for approximately 10% of all AML cases. Recently, several studies have been set out to obtain a comprehensive genome-wide view of the molecular actions of this chimeric protein. In this review, we highlight the new insights that arose from these studies, in particular focussing on newly identified PML-RARα target genes, its interplay with RXR and deregulation of epigenetic modifications.
Original language | English |
---|---|
Pages (from-to) | 554-558 |
Number of pages | 5 |
Journal | British Journal of Cancer |
Volume | 104 |
Issue number | 4 |
DOIs | |
Publication status | Published - 15 Feb 2011 |
Externally published | Yes |
Keywords
- epigenome
- PML-RARa
- PU.1 (SPI1)
- RXR